Toronto-based Attix Pharmaceuticals has received a US FDA warning letter after an inspection from November and a lack of corrective actions in the company’s response to the FDA.
Hospira has paid Orchid Chemicals and Pharmaceuticals $218m (€160m) for an API plant in Aurangabad, India to increase its antibiotics production capacity and cut reliance on external suppliers.
Hospira says bringing medical device manufacturing operations up to code will take 'a lot of work' after Lake Forest, Illinois plant is hit with US FDA Form 483.
Hospira has bought Orchid Chemicals and Pharmaceutical’s active pharmaceutical ingredient (API) facility in Aurangabad, India, to support its expanding antibiotic business.
DSM is expanding its anti-infectives production facilities in
India, as part of a global restructuring program to improve
profitability and retain DSM's position in the penicillin market.
The US subsidiary of India's Ranbaxy has launched a cephalosporin
antibiotic in a chewable tablet formulation designed to be easier
to take by patients who struggle with tablets or capsules.
DSM Anti-Infectives, the world's largest producer of antibiotics,
is planning to expand a manufacturing plant for a key intermediate
used in the manufacture of cephalosporins that will make it the
largest producer of the compound...
Recordati is expecting to sell off its pharmaceutical chemical
operations by the end of next year or early in 2004, according to
the company's chief executive, who expects €80-€90m in proceeds for
the sale.
